Insider trade

Windward Bio Group (WWB): Director bought ~$20M

David P Bonita, Director at Windward Bio Group, bought ~$20M of Windward Bio Group shares.

~$20M
Approx. value · 1.18M sh @ $17.00
1.71M
Holds after · shares reported
Traded
Nov 16, 2026
Filed
Nov 18, 2026

What stands out in this filing

  • The purchase added 221.3% to the shares this insider held before it; the filing reports 1,708,103 shares, held indirectly afterwards.
  • 1,176,471 shares at an average of $17.00 each, as reported on the form.
  • 2 other insiders at WWB also bought in the open market within 30 days.

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

Context

Written by software from the filings listed below · Nov 19, 2026

  • What was filed. David P Bonita, Director, reported an open-market purchase of about $20M of Windward Bio Group (WWB) shares (1,176,471 shares at $17.00 each). The transaction date was Nov 16, 2026 and the Form 4 was filed on Nov 18, 2026, 2 days later. (SEC Form 4)

4 more points, with the facts they come from, are in OQRO Pro.

Sign up free

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Nov 16, 2026 · this disclosureInsiderDirector purchased ~$20M of WWB shares in the open market

What came next

  1. Nov 16, 2026Insider · 2 peopleInsiders: 3 purchases (~$49.8M)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Windward Bio Group

For Windward Bio Group, OQRO holds 4 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its WWB page.

Other recent filings by David P Bonita, Director

The full history of David P Bonita, Director is on the profile page.

How this filing works

Explore the data

Common questions

Which Windward Bio Group (WWB) insider traded, and how much?

David P Bonita, Director at Windward Bio Group, bought ~$20M of Windward Bio Group shares. 1.18M shares at $17.00, open market.

When did it happen, and when was it made public?

Traded: Nov 16, 2026. Filed: Nov 18, 2026. That is 2 days between the two dates.

What stands out in this filing?

The purchase added 221.3% to the shares this insider held before it; the filing reports 1,708,103 shares, held indirectly afterwards. 1,176,471 shares at an average of $17.00 each, as reported on the form. 2 other insiders at WWB also bought in the open market within 30 days.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Windward Bio Group recently?

For Windward Bio Group, OQRO holds 4 insider filings (SEC Form 4 or Form 144) dated in the last 90 days. They are listed on the WWB page.

Does this mean WWB stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Windward Bio Group

Everything OQRO holds on this company is on its WWB page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data